TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2019

Phase II Trial of a DNA Vaccine Encoding Prostatic Acid Phosphatase (pTVG-HP [MVI-816]) in Patients With Progressive, Nonmetastatic, Castration-Sensitive Prostate Cancer.

Douglas G McNeel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.